Guest content Contributed by Jayme Norrie, Chief Strategic Officer, Incite World From what we have experienced, angel investors are shoring up the gap in new innovations coming forward. However, they seem to be more naive than VC’s in terms of due diligence prior to investing. Scientists from the company march in with charts and scientific […]
Guest content contributed by Agnes Shanley, Editor in Chief, Pharmaceutical Manufacturing Every day we read about severe shortages of skilled biotech workers in the U.S.. At the same time, the trend to pharma offshoring and outsourcing is becoming more pronounced, and is moving from traditional pharma to biopharma. We recently touched on some of these […]
A guest editorial from Emil Ciurczak, Contributing Editor, PharmaManufacturing.com While reading a trade magazine recently, I was struck with the detailed information on how to design and implement a Corrective and Preventive Action (CAPA) system. ISO 9001:200, Clause 8.5.2 states, “…the organization shall take action to eliminate the cause of nonconformities encountered…” For medical devices, […]
A common retort in the debate over drug reimportation is “Where are the dead Canadians?” If the FDA deems that import of drugs from Canada is potentially dangerous, why aren’t Canadians dying from drugs they buy in Canada? Well, there’s an answer to that: Most Canadians buy their drugs from drugstores, not over the Internet. […]
CnnMoney has a cool story on a mother who was motivated to start a biotech company to develop a better treatment for her daughter’s disease. A former lawyer and founder of satellite-communications companies including Sirius Satellite Radio, Martine Rothblatt was able to develop proficiency in biotechnology and her company, United Therapeutics, grossed $159 million in […]
Google’s posted more details on Google Health, including the announcement of their advisory board. Note that the comments to Google’s announcement decry a lack of librarians or diabetes experts.
Courtesy of DrugPatentWatch.com: Drug Patent Expirations in July 2007*Drugs may be covered by more than one patent Tradename Applicant Generic Name Patent Number Patent Expiration CETROTIDE Serono Inc cetrorelix 4,800,191 JUL 17,2007 DEMADEX Roche torsemide 4,861,786 JUL 08,2007 EXCEDRIN (MIGRAINE) Novartis acetaminophen; aspirin; caffeine 4,943,565 JUL 24,2007 TEGRETOL-XR Novartis carbamazepine RE34990 JUL 29,2007 TYLENOL (CAPLET) […]